Fundraising Fox

Christine Martin

Investor

Head of Ventures at University of Cambridge Enterprise

Greater Cambridge Area

About

Christine Martin is Head of Ventures at Cambridge Enterprise, overseeing investment activities with a focus on life sciences and drug discovery, and has backed University of Cambridge spin-outs including PhoreMost and Qkine. She joined in 2011 after roles in life sciences tech transfer and 11 years at biotech spin-out Biotica, and holds an MA and DPhil from the University of Oxford.

LinkedIn ↗

Invests in

BiotechDeep Tech

Experience

  1. Cambridge EnterpriseHead of Venturescurrent2021 — presentCambridge, England, United Kingdom
  2. Cambridge EnterpriseDeputy Head of Seed Funds2020 — 2021Cambridge, England, United Kingdom
  3. Cambridge EnterpriseHead of Life Science Investment2019 — 2020Greater Cambridge Area
  4. Cambridge EnterpriseActing Head of Seed Funds2020
  5. Cambridge EnterpriseInvestment Manager (Life Sciences)2017 — 2019Greater Cambridge Area
  6. Cambridge EnterpriseManager, Drug Discovery2012 — 2017
  7. Cambridge EnterpriseSenior Technology Associate2011 — 2012
  8. SDS TherapeuticsDirectorcurrent2020 — present
  9. SpireaDirectorcurrent2020 — present
  10. PolyProx Therapeutics LtdDirectorcurrent2019 — present
  11. QkineDirector2019 — 2022
  12. PharmEnableDirector2020 — 2022
  13. Bilitech LimitedBoard Observer2018 — 2022
  14. Carrick TherapeuticsBoard Observer2017 — 2022
  15. ConcrBoard Observer2021
  16. APCINTEX LIMITEDBoard Observer2017 — 2021
  17. Z FACTOR LIMITEDDirector2015 — 2021
  18. STORM Therapeutics LimitedBoard Observer2017 — 2019
  19. Biotica Technology LimitedSenior Director, Molecular Biology2009 — 2011
  20. Biotica Technology LimitedDirector, Molecular Biology2003 — 2009

Education

  1. University of OxfordMA, DPhil, Chemistry1988 — 1995

Same school

Also attended University of Oxford745

Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBrad GerstnerFounder & CEO of Altimeter CapitalDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index VenturesJan HammerInvestor at Index Ventures

+ 739 more

Shared employers

Also worked at Cambridge Enterprise9

Chris GibbsInvestment Director (Physical Sciences) at University of Cambridge EnterpriseAmanda WoodingDeputy Head of Ventures at University of Cambridge EnterpriseMegan Meredith-RodriguezInvestment Analyst (Deep Tech) at University of Cambridge EnterprisePiers HorlockInvestment Analyst at University of Cambridge EnterpriseGemma SiddallInvestment Associate (Sustainability) at University of Cambridge EnterpriseTom HallInvestment Director at Martlet Capital

+ 3 more

Also worked at PharmEnable1

Jeffrey MoorePresident at MC Healthcare Ventures

Also worked at Carrick Therapeutics3

Robert TansleyPartner at Cambridge Innovation CapitalCaroline GaynorPartner at Lightstone VenturesJason LettmannPartner at Morgenthaler

Also worked at Z FACTOR LIMITED1

Jon EdwardsGeneral Partner at Forbion

Investments

Investor

CarrickPhoreMostPolyProXQkineSTORMZ-factor

Per the firm's website.

Colleagues at University of Cambridge Enterprise

Amanda Wooding
Deputy Head of Ventures at University of Cambridge Enterprise
Chris Gibbs
Investment Director (Physical Sciences) at University of Cambridge Enterprise
Fatima Kranc
Investment Manager (Life Sciences) at University of Cambridge Enterprise
Gemma Siddall
Investment Associate (Sustainability) at University of Cambridge Enterprise
Loukik Arora
Principal Investment Associate (Life Science) at University of Cambridge Enterprise
Mahesh Santiapillai
Investment Manager (Software and DeepTech) at University of Cambridge Enterprise
Megan Meredith-Rodriguez
Investment Analyst (Deep Tech) at University of Cambridge Enterprise
Piers Horlock
Investment Analyst at University of Cambridge Enterprise